Theorem names VP, global business development
Theorem Clinical Research, previously Omnicare Clinical Research, has named Adam Serody vice president, global business development. In his new role, Serody will lead Theorem’s global sales, proposals and marketing organizations.
Most recently, Serody served as executive director of business development and global leader for phase IV at Pharmanet.
“His clinical background, proven sales track record, and expertise in driving marketing and proposals efforts provide Adam with a unique perspective on every aspect of not only the sales cycle, but also the clinical development cycle. With Adam leading our team, I believe we will be uniquely positioned for future success,” said John Potthoff, PhD, president and CEO of Theorem.